Robert G. Wright - 09 Feb 2024 Form 4 Insider Report for Delek US Holdings, Inc. (DK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Feb 2024, 20:17:02 UTC
Prior SEC filing
13 Jun 2023
Next SEC filing
12 Sep 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Misty Foy, Attorney in Fact

Key filing fact

Robert G. Wright filed Form 4 for Delek US Holdings, Inc. (DK) on 13 Feb 2024.

Key facts

  • This page summarizes Robert G. Wright's Form 4 filing for Delek US Holdings, Inc. (DK).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Feb 2024, 20:17.

Change

  • Previous filing in this sequence was filed on 13 Jun 2023.
  • Current net transaction value: -$63,014.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DK transaction

Common Stock

Sale

Transaction value
$2,508
Shares
-88
Change %
-0.42%
Price
$28.50
Shares after
21,048
Date
09 Feb 2024
Ownership
Direct
Footnotes
F1
DK transaction

Common Stock

Sale

Transaction value
$60,506
Shares
-2,123
Change %
-10%
Price
$28.50
Shares after
18,925
Date
12 Feb 2024
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This transaction for the sale of 88 shares at a price of $28.50/share was made pursuant to a 10b5-1 plan adopted on August 11, 2023, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Footnote F2

This transaction for the sale of 2,123 shares at a price of $28.50/share was made pursuant to a 10b5-1 plan adopted on August 11, 2023, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .